Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 70

1.

Post-mumps acute disseminated encephalomyelitis in an adolescent.

Rehani V, Mahto SK, Sheoran A, Singh A, Verma P, Kaushik K.

J Family Med Prim Care. 2019 Jul;8(7):2533-2535. doi: 10.4103/jfmpc.jfmpc_437_19.

2.

Leukocytoclastic vasculitis: An uncommon adverse effect of a common drug.

Sheoran A, Mahto SK, Verma P, War GA, Agarwal N, Singh A.

J Family Med Prim Care. 2019 Jun;8(6):2137-2139. doi: 10.4103/jfmpc.jfmpc_338_19.

3.

Evaluation of in silico designed inhibitors targeting MelF (Rv1936) against Mycobacterium marinum within macrophages.

Dharra R, Radhakrishnan VS, Prasad T, Thakur Z, Cirillo JD, Sheoran A, Pandey AK, Kulharia M, Mehta PK.

Sci Rep. 2019 Jul 12;9(1):10084. doi: 10.1038/s41598-019-46295-5.

4.

Complex regional pain syndrome-A forgotten entity.

Gupta PK, Gupta PK, Mahto SK, Sheoran A, Singh U, Bhandarkar A, Gupta U, Hayaran N.

J Family Med Prim Care. 2019 May;8(5):1778-1780. doi: 10.4103/jfmpc.jfmpc_193_19.

5.

A Rare and Lethal Complication of Oral Warfarin Therapy.

Mahto SK, Sheoran A, Agarwal N, Verma P, Goel A.

Indian J Crit Care Med. 2019 Apr;23(4):197-198. doi: 10.5005/jp-journals-10071-23156.

6.

Quantitative detection of a cocktail of mycobacterial MPT64 and PstS1 in tuberculosis patients by real-time immuno-PCR.

Sharma S, Sheoran A, Gupta KB, Yadav A, Varma-Basil M, Sreenivas V, Chaudhary D, Mehta PK.

Future Microbiol. 2019 Feb;14:223-233. doi: 10.2217/fmb-2018-0284. Epub 2019 Jan 21.

PMID:
30663893
7.

Uncommon Cause of Acute Liver Failure with Encephalopathy.

Mahto SK, Sheoran A, Goel A, Agarwal N.

Indian J Crit Care Med. 2018 Aug;22(8):619-620. doi: 10.4103/ijccm.IJCCM_244_18. No abstract available.

8.

Comparative evaluation of GeneXpert MTB/RIF and multiplex PCR targeting mpb64 and IS6110 for the diagnosis of pleural TB.

Sharma S, Dahiya B, Sreenivas V, Singh N, Raj A, Sheoran A, Yadav A, Gupta KB, Mehta PK.

Future Microbiol. 2018 Mar;13:407-413. doi: 10.2217/fmb-2017-0147. Epub 2018 Feb 21.

PMID:
29464970
9.

Infection with anthroponotic Cryptosporidium parvum does not fully protect the host against a subsequent challenge with C. hominis.

Sheoran AS, Pina-Mimbela R, Keleher A, Girouard D, Tzipori S.

Microbes Infect. 2018 Apr;20(4):267-270. doi: 10.1016/j.micinf.2018.01.001. Epub 2018 Jan 31.

10.

Cryptosporidium hominis gene catalog: a resource for the selection of novel Cryptosporidium vaccine candidates.

Ifeonu OO, Simon R, Tennant SM, Sheoran AS, Daly MC, Felix V, Kissinger JC, Widmer G, Levine MM, Tzipori S, Silva JC.

Database (Oxford). 2016 Oct 19;2016. pii: baw137. doi: 10.1093/database/baw137. Print 2016.

11.

Development of real-time immuno-PCR for the quantitative detection of mycobacterial PstS1 in tuberculosis patients.

Sharma S, Raj A, Singh N, Dahiya B, Sheoran A, Gupta KB, Mehta PK.

J Microbiol Methods. 2017 Jan;132:134-138. doi: 10.1016/j.mimet.2016.12.006. Epub 2016 Dec 7.

PMID:
27940201
12.

Diagnosis of tuberculosis based on the detection of a cocktail of mycobacterial antigen 85B, ESAT-6 and cord factor by immuno-PCR.

Mehta PK, Singh N, Dharra R, Dahiya B, Sharma S, Sheoran A, Gupta KB, Chaudhary D, Mehta N, Varma-Basil M.

J Microbiol Methods. 2016 Aug;127:24-27. doi: 10.1016/j.mimet.2016.05.003. Epub 2016 May 7.

PMID:
27164021
13.

Serodiagnostic potential of immuno-PCR using a cocktail of mycobacterial antigen 85B, ESAT-6 and cord factor in tuberculosis patients.

Singh N, Sreenivas V, Sheoran A, Sharma S, Gupta KB, Khuller GK, Mehta PK.

J Microbiol Methods. 2016 Jan;120:56-64. doi: 10.1016/j.mimet.2015.11.016. Epub 2015 Nov 25.

PMID:
26625715
14.

Adenovirus vector expressing Stx1/Stx2-neutralizing agent protects piglets infected with Escherichia coli O157:H7 against fatal systemic intoxication.

Sheoran AS, Dmitriev IP, Kashentseva EA, Cohen O, Mukherjee J, Debatis M, Shearer J, Tremblay JM, Beamer G, Curiel DT, Shoemaker CB, Tzipori S.

Infect Immun. 2015 Jan;83(1):286-91. doi: 10.1128/IAI.02360-14. Epub 2014 Nov 3.

15.

Selective Evolution of Ligands by Exponential Enrichment to Identify RNA Aptamers against Shiga Toxins.

Challa S, Tzipori S, Sheoran A.

J Nucleic Acids. 2014;2014:214929. doi: 10.1155/2014/214929. Epub 2014 Apr 15.

16.

A single VHH-based toxin-neutralizing agent and an effector antibody protect mice against challenge with Shiga toxins 1 and 2.

Tremblay JM, Mukherjee J, Leysath CE, Debatis M, Ofori K, Baldwin K, Boucher C, Peters R, Beamer G, Sheoran A, Bedenice D, Tzipori S, Shoemaker CB.

Infect Immun. 2013 Dec;81(12):4592-603. doi: 10.1128/IAI.01033-13. Epub 2013 Sep 30.

17.

Discovery of a novel class of boron-based antibacterials with activity against gram-negative bacteria.

Hernandez V, Crépin T, Palencia A, Cusack S, Akama T, Baker SJ, Bu W, Feng L, Freund YR, Liu L, Meewan M, Mohan M, Mao W, Rock FL, Sexton H, Sheoran A, Zhang Y, Zhang YK, Zhou Y, Nieman JA, Anugula MR, Keramane el M, Savariraj K, Reddy DS, Sharma R, Subedi R, Singh R, O'Leary A, Simon NL, De Marsh PL, Mushtaq S, Warner M, Livermore DM, Alley MR, Plattner JJ.

Antimicrob Agents Chemother. 2013 Mar;57(3):1394-403. doi: 10.1128/AAC.02058-12. Epub 2013 Jan 7.

18.

Biodistribution and elimination kinetics of systemic Stx2 by the Stx2A and Stx2B subunit-specific human monoclonal antibodies in mice.

Sheoran A, Jeong KI, Mukherjee J, Wiffin A, Singh P, Tzipori S.

BMC Immunol. 2012 Jun 1;13:27. doi: 10.1186/1471-2172-13-27.

19.

Infection with Cryptosporidium hominis provides incomplete protection of the host against Cryptosporidium parvum.

Sheoran A, Wiffin A, Widmer G, Singh P, Tzipori S.

J Infect Dis. 2012 Mar 15;205(6):1019-23. doi: 10.1093/infdis/jir874. Epub 2012 Jan 25.

20.

Association of Streptococcus equi with equine monocytes.

Mérant C, Sheoran A, Timoney JF.

Vet Immunol Immunopathol. 2011 Sep 15;143(1-2):83-6. doi: 10.1016/j.vetimm.2011.06.027. Epub 2011 Jun 23.

PMID:
21752476
21.
22.

Comparative study of cellulose waste versus organic waste as substrate in a sulfate reducing bioreactor.

Choudhary RP, Sheoran AS.

Bioresour Technol. 2011 Mar;102(6):4319-24. doi: 10.1016/j.biortech.2010.08.126. Epub 2010 Sep 6.

PMID:
20926292
23.

In vitro and in vivo protective efficacies of antibodies that neutralize the RNA N-glycosidase activity of Shiga toxin 2.

Jeong KI, Chapman-Bonofiglio S, Singh P, Lee J, Tzipori S, Sheoran AS.

BMC Immunol. 2010 Mar 24;11:16. doi: 10.1186/1471-2172-11-16.

25.

Evaluation of Fab and F(ab')2 fragments and isotype variants of a recombinant human monoclonal antibody against Shiga toxin 2.

Akiyoshi DE, Sheoran AS, Rich CM, Richard L, Chapman-Bonofiglio S, Tzipori S.

Infect Immun. 2010 Mar;78(3):1376-82. doi: 10.1128/IAI.00867-09. Epub 2010 Jan 19.

26.

Structural investigation and electron paramagnetic resonance of vanadyl doped alkali niobium borate glasses.

Agarwal A, Sheoran A, Sanghi S, Bhatnagar V, Gupta SK, Arora M.

Spectrochim Acta A Mol Biomol Spectrosc. 2010 Mar;75(3):964-9. doi: 10.1016/j.saa.2009.12.003. Epub 2009 Dec 6.

PMID:
20060775
27.

Affects of N-terminal variation in the SeM protein of Streptococcus equi on antibody and fibrinogen binding.

Timoney JF, DeNegri R, Sheoran A, Forster N.

Vaccine. 2010 Feb 10;28(6):1522-7. doi: 10.1016/j.vaccine.2009.11.064. Epub 2009 Dec 14.

PMID:
20005857
28.

Over-expression and localization of a host protein on the membrane of Cryptosporidium parvum infected epithelial cells.

Yang YL, Serrano MG, Sheoran AS, Manque PA, Buck GA, Widmer G.

Mol Biochem Parasitol. 2009 Nov;168(1):95-101. doi: 10.1016/j.molbiopara.2009.07.004. Epub 2009 Jul 22.

29.

Cryptosporidium parvum DNA replication in cell-free culture.

Zhang L, Sheoran AS, Widmer G.

J Parasitol. 2009 Oct;95(5):1239-42. doi: 10.1645/GE-2052.1. Epub 2009 May 23.

30.

A nonradioactive high-throughput assay for screening and characterization of adenylation domains for nonribosomal peptide combinatorial biosynthesis.

McQuade TJ, Shallop AD, Sheoran A, Delproposto JE, Tsodikov OV, Garneau-Tsodikova S.

Anal Biochem. 2009 Mar 15;386(2):244-50. doi: 10.1016/j.ab.2008.12.014. Epub 2008 Dec 24.

PMID:
19135023
31.

Characterization of TioF, a tryptophan 2,3-dioxygenase involved in 3-hydroxyquinaldic acid formation during thiocoraline biosynthesis.

Sheoran A, King A, Velasco A, Pero JM, Garneau-Tsodikova S.

Mol Biosyst. 2008 Jun;4(6):622-8. doi: 10.1039/b801391h. Epub 2008 Apr 4.

PMID:
18493661
32.
33.
34.

Intracellular neutralization of shiga toxin 2 by an a subunit-specific human monoclonal antibody.

Krautz-Peterson G, Chapman-Bonofiglio S, Boisvert K, Feng H, Herman IM, Tzipori S, Sheoran AS.

Infect Immun. 2008 May;76(5):1931-9. doi: 10.1128/IAI.01282-07. Epub 2008 Feb 19.

35.

Quantitative tracking of Cryptosporidium infection in cell culture with CFSE.

Feng H, Nie W, Bonilla R, Widmer G, Sheoran A, Tzipori S.

J Parasitol. 2006 Dec;92(6):1350-4.

PMID:
17304819
36.

Serial propagation of the microsporidian Enterocytozoon bieneusi of human origin in immunocompromised rodents.

Feng X, Akiyoshi DE, Sheoran A, Singh I, Hanawalt J, Zhang Q, Widmer G, Tzipori S.

Infect Immun. 2006 Aug;74(8):4424-9.

37.

Bile acids enhance invasiveness of Cryptosporidium spp. into cultured cells.

Feng H, Nie W, Sheoran A, Zhang Q, Tzipori S.

Infect Immun. 2006 Jun;74(6):3342-6.

39.

Monoclonal antibodies against Enterocytozoon bieneusi of human origin.

Sheoran AS, Feng X, Singh I, Chapman-Bonofiglio S, Kitaka S, Hanawalt J, Nunnari J, Mansfield K, Tumwine JK, Tzipori S.

Clin Diagn Lab Immunol. 2005 Sep;12(9):1109-13.

40.

Production and characterization of monoclonal antibodies against Enterocytozoon bieneusi purified from rhesus macaques.

Zhang Q, Singh I, Sheoran A, Feng X, Nunnari J, Carville A, Tzipori S.

Infect Immun. 2005 Aug;73(8):5166-72.

41.

Human antibody against shiga toxin 2 administered to piglets after the onset of diarrhea due to Escherichia coli O157:H7 prevents fatal systemic complications.

Sheoran AS, Chapman-Bonofiglio S, Harvey BR, Mukherjee J, Georgiou G, Donohue-Rolfe A, Tzipori S.

Infect Immun. 2005 Aug;73(8):4607-13.

42.

Characterization of a human monoclonal antibody against Shiga toxin 2 expressed in Chinese hamster ovary cells.

Akiyoshi DE, Rich CM, O'Sullivan-Murphy S, Richard L, Dilo J, Donohue-Rolfe A, Sheoran AS, Chapman-Bonofiglio S, Tzipori S.

Infect Immun. 2005 Jul;73(7):4054-61.

43.

Purification of Enterocytozoon bieneusi from stools and production of specific antibodies.

Sheoran AS, Feng X, Kitaka S, Green L, Pearson C, Didier ES, Chapman S, Tumwine JK, Tzipori S.

J Clin Microbiol. 2005 Jan;43(1):387-92.

44.

Antibody therapy in the management of shiga toxin-induced hemolytic uremic syndrome.

Tzipori S, Sheoran A, Akiyoshi D, Donohue-Rolfe A, Trachtman H.

Clin Microbiol Rev. 2004 Oct;17(4):926-41, table of contents. Review.

45.

Characterization of RAP, a quorum sensing activator of Staphylococcus aureus.

Korem M, Sheoran AS, Gov Y, Tzipori S, Borovok I, Balaban N.

FEMS Microbiol Lett. 2003 Jun 27;223(2):167-75.

46.

Stx2-specific human monoclonal antibodies protect mice against lethal infection with Escherichia coli expressing Stx2 variants.

Sheoran AS, Chapman S, Singh P, Donohue-Rolfe A, Tzipori S.

Infect Immun. 2003 Jun;71(6):3125-30.

47.

Purification strategies for microbial lipases.

Saxena RK, Sheoran A, Giri B, Davidson WS.

J Microbiol Methods. 2003 Jan;52(1):1-18. Review.

PMID:
12401222
48.

Variability among Cryptosporidium parvum genotype 1 and 2 immunodominant surface glycoproteins.

Sestak K, Ward LA, Sheoran A, Feng X, Akiyoshi DE, Ward HD, Tzipori S.

Parasite Immunol. 2002 Apr;24(4):213-9.

49.

Nasal mucosal immunogenicity for the horse of a SeM peptide of Streptococcus equi genetically coupled to cholera toxin.

Sheoran AS, Artiushin S, Timoney JF.

Vaccine. 2002 Feb 22;20(11-12):1653-9. Erratum in: Vaccine. 2003 May 16;21(17-18):2221.

PMID:
11858875
50.

Characterization and immunogenicity of pyrogenic mitogens SePE-H and SePE-I of Streptococcus equi.

Artiushin SC, Timoney JF, Sheoran AS, Muthupalani SK.

Microb Pathog. 2002 Feb;32(2):71-85.

PMID:
11812213

Supplemental Content

Loading ...
Support Center